Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$145M |
| 2 |
Fortis
FTS
|
+$68.9M |
| 3 |
Intuitive Surgical
ISRG
|
+$47.9M |
| 4 |
Keurig Dr Pepper
KDP
|
+$39.6M |
| 5 |
Medtronic
MDT
|
+$34.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
+$63.4M |
| 2 |
Hershey
HSY
|
+$51.3M |
| 3 |
American Tower
AMT
|
+$50.3M |
| 4 |
Alcoa
AA
|
+$34.6M |
| 5 |
LLL
L3 Technologies, Inc.
LLL
|
+$32.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.54% |
| 2 | Healthcare | 14.34% |
| 3 | Industrials | 10.58% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Communication Services | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Bio-Techne
TECH
$11.2B
| $6.3M | 0.01% |
245,244
+4,000
| +2% | +$105K |
|
827
Watsco Inc
WSO
$13.2B
| $6.29M | 0.01% |
42,444
+900
| +2% | +$130K |
|
828
Woodward
WWD
$21.1B
| $6.28M | 0.01% |
91,000
+2,700
| +3% | +$175K |
|
829
Bank of Hawaii
BOH
$3.13B
| $6.25M | 0.01% |
70,437
+900
| +1% | +$73K |
|
830
Manhattan Associates
MANH
$11.4B
| $6.24M | 0.01% |
117,720
+1,800
| +2% | +$96K |
|
|
STOR
831
DELISTED
STORE Capital Corporation
STOR
| $6.22M | 0.01% |
251,940
+6,300
| +3% | +$163K |
|
832
United Bankshares
UBSI
$6.61B
| $6.22M | 0.01% |
134,581
+21,700
| +19% | +$921K |
|
833
Bio-Rad Laboratories Class A
BIO
$9.53B
| $6.2M | 0.01% |
34,007
+700
| +2% | +$119K |
|
|
TCF
834
DELISTED
TCF Financial Corporation Common Stock
TCF
| $6.19M | 0.01% |
114,203
-8,200
| -7% | -$399K |
|
835
Wintrust Financial
WTFC
$10.9B
| $6.16M | 0.01% |
84,867
+1,900
| +2% | +$118K |
|
|
HOUS
836
DELISTED
Anywhere Real Estate
HOUS
| $6.14M | 0.01% |
238,500
-166,100
| -41% | -$4.11M |
|
837
Ziff Davis
ZD
$1.83B
| $6.13M | 0.01% |
86,171
+1,265
| +1% | +$80.4K |
|
|
MPT
838
Medical Properties Trust
MPT
$2.4B
| $6.11M | 0.01% |
496,900
+13,700
| +3% | +$177K |
|
|
UNIT
839
Uniti Group
UNIT
$2.25B
| $6.11M | 0.01% |
240,374
-5,100
| -2% | -$137K |
|
|
CST
840
DELISTED
CST Brands, Inc.
CST
| $6.11M | 0.01% |
126,800
| – | – |
|
841
Encompass Health
EHC
$12.4B
| $6.09M | 0.01% |
185,533
+2,388
| +1% | +$77.5K |
|
842
Associated Banc-Corp
ASB
$6.02B
| $6.08M | 0.01% |
246,000
| – | – |
|
843
BWX Technologies
BWXT
$15.5B
| $6.07M | 0.01% |
153,000
| – | – |
|
844
Fair Isaac
FICO
$22.4B
| $6.06M | 0.01% |
50,800
+600
| +1% | +$71.3K |
|
845
Flowers Foods
FLO
$1.52B
| $6.05M | 0.01% |
302,863
| – | – |
|
846
IPG Photonics
IPGP
$3.65B
| $6.04M | 0.01% |
61,199
+1,800
| +3% | +$168K |
|
|
HRC
847
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $6.04M | 0.01% |
107,600
+1,800
| +2% | +$102K |
|
|
CY
848
DELISTED
Cypress Semiconductor
CY
| $6.04M | 0.01% |
528,045
+22,600
| +4% | +$248K |
|
|
IBKC
849
DELISTED
IBERIABANK Corp
IBKC
| $6.02M | 0.01% |
71,923
+5,200
| +8% | +$398K |
|
|
TARO
850
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $6M | 0.01% |
57,000
-70,200
| -55% | -$7.35M |
|
Similar funds
Swiss National Bank's Q4 2016 Portfolio in Review
As of Q4 2016, Swiss National Bank held 2,615 positions worth $63.4B, up 1.6% from $62.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2016: portfolio turnover was 5%. Swiss National Bank opened 79 new positions and exited 51, leaving the 2,615-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.
- Swiss National Bank's largest Q4 2016 buy was Teva Pharmaceuticals: 3,630,251 shares worth $132M.
- Swiss National Bank added most to Intuitive Surgical in Q4 2016, an estimated $47.9M increase.
- Swiss National Bank's biggest Q4 2016 reduction was Hershey, cutting an estimated $51.3M.
- Swiss National Bank fully exited LinkedIn Corporation in Q4 2016, selling an estimated $63.4M.
- Swiss National Bank's ten largest holdings make up 15% of its $63.4B portfolio in Q4 2016.
- Swiss National Bank opened 79 new positions and closed 51 in Q4 2016.
- Swiss National Bank's portfolio value rose 1.6% quarter-over-quarter to $63.4B.
Based on Swiss National Bank's 13F filing for Q4 2016, filed 8 Feb 2017.